Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 1998

View Archived Issues

Company Profile: Millennium

Clinical development of LM-AS-013 advances at Green Cross

Inhibitors of the production or release of sCD23, TNF

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

New excitatory amino acid antagonists in development at Pfizer

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Triangle reports results from phase I/II FTC trial

Tsumura team reveals semisynthetic huperzine derivatives

More new agents for influenza from Lilly

PMPA reduces viral load in phase I/II

Potent, orally active inhibitor of kynurenine 3-hydroxylase discovered at Roche

Diphenylalkylamine derivative with cardioprotective properties characterized

ArQule and CuraGen establish broad drug discovery collaboration

Comparative trial of intracavernous alprostadil and MUSE for ED

Swiss Remune trials initiated

Long-term efficacy of epoprostenol for primary pulmonary hypertension

Optison imaging agent launched in U.S.

FDA advisory committee recommends Integrilin approval

Hybridon antitumor antisense compound enters clinical trials

Folic acid therapy and cardiovascular risk reduction

Anesta signs European marketing agreement for Actiq

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...